PAVS - Paranovus Entertainment Technology Ltd.

QQQ $ 442.84 $ 1.02 (0.23 %)

DIA $ 394.52 $ -0.72 (-0.18 %)

SPY $ 520.61 $ 0.07 (0.01 %)

TLT $ 90.36 $ 0.23 (0.26 %)

GLD $ 216.28 $ -2.45 (-1.12 %)

Previous Close

$ 1.01

Open

$ 1.26

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.26 - $ 1.26

52 Week Range

$ 0.99 - $ 4.84

Volume

1,385

Average Volume

Market Cap

8.42M

Beta (5Y Monthly)

$ 0.26

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Paranovus Entertainment Appointed Ling Guo...
05/03/2024 20:41:13

Paranovus Entertainment Technology CFO Sop...
05/03/2024 20:38:38

11-consumer-staples-stocks-moving-in-tuesdays-pre-market-session

11 Consumer Staples Stocks Moving In Tuesd...
12/26/2023 13:07:15

12-consumer-staples-stocks-moving-in-fridays-intraday-session

12 Consumer Staples Stocks Moving In Frida...
11/17/2023 17:31:16

11-consumer-staples-stocks-moving-in-thursdays-intraday-session

11 Consumer Staples Stocks Moving In Thurs...
11/16/2023 17:31:11

Paranovus Signs Software Development Agree...
11/15/2023 13:34:46

Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS) (the "Company") announced today that it has entered into a softwa...

Paranovus Entertainment Technology Ltd Sig...
09/06/2023 12:36:47

Expansion into AI-powered online entertainment industry reflects strategic evolution of the business model NANPING, China, Se...

why-baidu-shares-are-trading-higher-by-more-than-6-here-are-other-stocks-moving-in-fridays-mid-day-session

Why Baidu Shares Are Trading Higher By Mor...
03/17/2023 16:49:21

Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laborator...